NYSE:ZBH

Zimmer Biomet - ZBH Stock Forecast, Price & News

$129.20

+2.44 (+1.92%)

(As of 03/31/2023 12:00 AM ET)

Add

Compare

Today's Range: $127.69
▼
$129.32
50-Day Range: $121.91
▼
$130.94
52-Week Range: $100.39
▼
$135.05

Volume: 1.21 million shs
Average Volume: 1.18 million shs
Market Capitalization: $27.00 billion

P/E Ratio: 117.45
Dividend Yield: 0.74%
Price Target: $133.06

Institutional Ownership

Zimmer Biomet MarketRank™ Forecast

Analyst Rating: Hold
2.23 Rating Score
Upside/Downside: 3.0% Upside
$133.06 Price Target
Short Interest: Healthy
1.60% of Shares Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -1.33
Upright™ Environmental Score
News Sentiment: 0.90
Based on 15 Articles This Week
Insider Trading: Selling Shares
$2.87 M Sold Last Quarter
Proj. Earnings Growth: 7.24%
From $7.04 to $7.55 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars

Medical Sector

307th out of 1,004 stocks

Surgical Appliances & Supplies Industry

8th out of 22 stocks

2.1

Analyst's Opinion

Consensus Rating
Zimmer Biomet has received a consensus rating of Hold. The company's average rating score is 2.23, and is based on 5 buy ratings, 6 hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $133.06, Zimmer Biomet has a forecasted upside of 3.0% from its current price of $129.20.
Amount of Analyst Coverage
Zimmer Biomet has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
1.60% of the outstanding shares of Zimmer Biomet have been sold short.
Short Interest Ratio / Days to Cover
Zimmer Biomet has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Zimmer Biomet has recently increased by 6.01%, indicating that investor sentiment is decreasing significantly.

0.8

Dividend Strength

Dividend Yield
Zimmer Biomet has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Zimmer Biomet does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Zimmer Biomet is 87.27%. Payout ratios above 75% are not desirable because they may not be sustainable.
Dividend Sustainability
Based on earnings estimates, Zimmer Biomet will have a dividend payout ratio of 12.72% next year. This indicates that Zimmer Biomet will be able to sustain or increase its dividend.

3.7

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Zimmer Biomet has received a 47.23% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Dental prostheses", "Surgery simulation software", "Dental implants", and "Prostheses" products. See details.
Environmental Sustainability
The Environmental Impact score for Zimmer Biomet is -1.33.

2.7

News and Social Media Coverage

News Sentiment
Zimmer Biomet has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 15 news articles for Zimmer Biomet this week, compared to 5 articles on an average week.
Search Interest
Only 7 people have searched for ZBH on MarketBeat in the last 30 days. This is a decrease of -36% compared to the previous 30 days.
MarketBeat Follows
Only 4 people have added Zimmer Biomet to their MarketBeat watchlist in the last 30 days. This is a decrease of -99% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Zimmer Biomet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,869,102.00 in company stock.
Percentage Held by Insiders
Only 0.73% of the stock of Zimmer Biomet is held by insiders.
Percentage Held by Institutions
87.21% of the stock of Zimmer Biomet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Zimmer Biomet are expected to grow by 7.24% in the coming year, from $7.04 to $7.55 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Zimmer Biomet is 117.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 118.71.
Price to Earnings Ratio vs. Sector
The P/E ratio of Zimmer Biomet is 117.45, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 76.39.
Price to Earnings Growth Ratio
Zimmer Biomet has a PEG Ratio of 2.90. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Zimmer Biomet has a P/B Ratio of 2.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Zimmer Biomet (NYSE:ZBH) Stock

Zimmer Biomet Holdings Inc is a medical technology company that designs, develops and manufactures a wide range of orthopedic and musculoskeletal products. With headquarters in Warsaw, Indiana, the company was formed in 2015 after the merger of Zimmer Holdings and Biomet Inc, two of the world's leading companies in the orthopedic industry. Zimmer Biomet's mission is to help people alleviate pain, regain mobility and improve the quality of life for patients worldwide.

The company's leadership team is led by President and CEO Bryan Hanson, who has been in his current role since 2017. Hanson has over 30 years of experience in the medical device industry and has held various executive positions in leading medical device companies. Additionally, Zimmer Biomet's executive team includes Chief Financial Officer Suketu Upadhyay and Chief Operating Officer Ivan Tornos.

Over the past few years, Zimmer Biomet has reported steady financial performance. The company has reported increased revenue and profit margin for the past several years while also reporting a debt-to-equity ratio indicating a relatively low debt level. In 2021, the company also announced a share repurchase program of up to $1 billion, demonstrating its commitment to returning value to shareholders.

Zimmer Biomet's stock performance has been mixed over the past few years. In early 2020, the company's stock price experienced a sharp decline due to the COVID-19 pandemic, but since then, it has rebounded and continues to experience volatility.

The orthopedic industry is highly competitive, with a few major players dominating the market. Zimmer Biomet is one of the largest companies in the industry, with a strong presence in the joint reconstruction, spine, dental, and sports medicine markets. The industry is also highly regulated, with various regulatory bodies overseeing the safety and efficacy of medical devices. Zimmer Biomet has a track record of complying with regulatory requirements and maintaining high-quality standards.

Zimmer Biomet is expanding its product portfolio through innovation and acquisitions. The company has a robust pipeline of new products in development, including the Persona Revision Knee System and the ROSA Knee System. Zimmer Biomet is also pursuing strategic acquisitions to expand its presence in emerging markets and strengthen its position in existing markets.

One of the most significant risks facing Zimmer Biomet is the potential for regulatory changes that could impact the industry. Changes in regulatory requirements could increase the costs and time required to bring new products to market, affecting Zimmer Biomet's ability to innovate and compete. In addition, insurance and hospital reimbursement policy changes could also impact the demand for Zimmer Biomet's products.

Another risk facing Zimmer Biomet is the potential for increased competition. While the company is one of the most significant players in the orthopedic industry, it faces competition from other established companies and new entrants. To maintain its market position, Zimmer Biomet must continue to innovate and invest in research and development.

Finally, changes in consumer preferences and healthcare trends could impact demand for Zimmer Biomet's products. For example, the increasing popularity of non-surgical treatments for orthopedic conditions could affect the demand for joint replacement products.

Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Stock News Headlines

March 31, 2023 | finance.yahoo.com

AngioDynamics (ANGO) Q3 Earnings Lag Estimates, FY23 View Cut

March 31, 2023 | msn.com

Jefferies Upgrades Zimmer Biomet Holdings (ZBH)

April 1, 2023 | Vantage Point (Ad)

What To Do With Your Trades Today

There’s a tool that scans and picks the best stocks… and could give you all the consistency you need in your trading… No matter what happens in the market. Revealed Here: A.I. Predicted Stock Forecasts

March 30, 2023 | americanbankingnews.com

UBS Group Initiates Coverage on Zimmer Biomet (NYSE:ZBH)

March 29, 2023 | msn.com

UBS Initiates Coverage of Zimmer Biomet Holdings (ZBH) with Sell Recommendation

March 29, 2023 | finance.yahoo.com

Zimmer Biomet's ROSA HIP with ONE Planner Hip Awarded Orthopaedic Product Innovation of the Year by Healthcare Asia Medtech Awards 2023

March 29, 2023 | benzinga.com

10 Analysts Have This to Say About Zimmer Biomet Holdings

March 27, 2023 | americanbankingnews.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Consensus Rating of "Hold" by Brokerages

April 1, 2023 | Vantage Point (Ad)

What To Do With Your Trades Today

March 24, 2023 | nasdaq.com

Cash Dividend On The Way From Zimmer Biomet Holdings (ZBH)

March 23, 2023 | msn.com

Zimmer Biomet Holdings: Dividend Insights

March 23, 2023 | americanbankingnews.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) VP Sells $2,869,102.50 in Stock

March 17, 2023 | finance.yahoo.com

QuidelOrtho (QDEL) Down 4.8% Since Last Earnings Report: Can It Rebound?

March 17, 2023 | marketwatch.com

Zimmer Biomet Holdings Inc. stock rises Thursday, still underperforms market

March 11, 2023 | msn.com

Piper Sandler Upgrades Zimmer Biomet Holdings (ZBH)

March 10, 2023 | nasdaq.com

First Week of ZBH April 21st Options Trading

March 10, 2023 | msn.com

Zimmer Biomet Holdings (ZBH) Declares $0.24 Dividend

March 7, 2023 | finance.yahoo.com

Zimmer Biomet Unveils Latest Enhancements to ZBEdge™ Dynamic Intelligence™ at AAOS 2023 Annual Meeting

March 3, 2023 | finance.yahoo.com

Zimmer Biomet (ZBH) Gains From Market Recovery, Global Growth

March 2, 2023 | msn.com

ZimVie crashes 37% to hit a post IPO-low after Q4 earnings

March 1, 2023 | marketwatch.com

Zimmer Biomet Holdings Inc. stock falls Wednesday, underperforms market

February 9, 2023 | finance.yahoo.com

3 Medical Products Stocks Navigating Industry Challenges

February 9, 2023 | finance.yahoo.com

Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?

February 7, 2023 | finance.yahoo.com

Investors in Zimmer Biomet Holdings (NYSE:ZBH) have unfortunately lost 15% over the last three years

February 6, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Hologic (HOLX) and Zimmer Biomet Holdings (ZBH)

February 6, 2023 | markets.businessinsider.com

Jefferies Reaffirms Their Sell Rating on Zimmer Biomet Holdings (ZBH)

February 6, 2023 | finance.yahoo.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2022 Earnings Call Transcript

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Company Calendar

Ex-Dividend for 1/31 Dividend: 12/23/2022
Dividend Payable: 1/31/2023
Last Earnings: 2/03/2023
Ex-Dividend for 4/28 Dividend: 3/28/2023
Today: 4/01/2023
Dividend Payable: 4/28/2023
Next Earnings (Estimated): 5/02/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:ZBH
Previous Symbol: NYSE:ZMH
CUSIP: N/A
CIK: 1136869
Web: www.zimmerbiomet.com
Phone: (574) 267-6131
Fax: 574-372-4988
Employees: 18,000
Year Founded: 1927

Price Target and Rating

Average Stock Price Forecast: $133.06
High Stock Price Forecast: $145.00
Low Stock Price Forecast: $104.00
Forecasted Upside/Downside: +2.3%
Consensus Rating: Hold
Rating Score (0-4): 2.15
Research Coverage: 13 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.10
Trailing P/E Ratio: 117.45
Forward P/E Ratio: 18.35
P/E Growth: 2.89
Net Income: $231.40 million
Net Margins: 3.33%
Pretax Margin: 5.81%
Return on Equity: 11.97%
Return on Assets: 6.78%

Debt

Debt-to-Equity Ratio: 0.43
Current Ratio: 1.88
Quick Ratio: 0.97

Sales & Book Value

Annual Sales: $6.94 billion
Price / Sales: 3.89
Cash Flow: $13.02 per share
Price / Cash Flow: 9.92
Book Value: $57.31 per share
Price / Book: 2.25

Miscellaneous

Outstanding Shares: 208,980,000
Free Float: 207,454,000
Market Cap: $27.00 billion
Optionable: Optionable
Beta: 1.00

Social Links

Key Executives

Bryan C. Hanson
Chairman, President & Chief Executive Officer

Ivan Tornos
Chief Operating Officer

Suketu P. Upadhyay
Chief Financial Officer & Executive Vice President

Zeeshan Tariq
Chief Information Officer & Senior Vice President

Angela Main
Chief Compliance Officer & Senior Vice President

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ZBH Stock - Frequently Asked Questions

Should I buy or sell Zimmer Biomet stock right now?: 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last twelve months. There are currently 2 sell ratings, 6 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ZBH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZBH, but not buy additional shares or sell existing shares.
View ZBH analyst ratings or view top-rated stocks.
What is Zimmer Biomet's stock price forecast for 2023?: 13 Wall Street research analysts have issued 12 month price objectives for Zimmer Biomet's stock. Their ZBH share price forecasts range from $104.00 to $145.00. On average, they predict the company's share price to reach $133.06 in the next twelve months. This suggests a possible upside of 3.0% from the stock's current price.
View analysts price targets for ZBH or view top-rated stocks among Wall Street analysts.
How have ZBH shares performed in 2023?: Zimmer Biomet's stock was trading at $127.50 at the beginning of the year. Since then, ZBH shares have increased by 1.3% and is now trading at $129.20.
View the best growth stocks for 2023 here.
Are investors shorting Zimmer Biomet?: Zimmer Biomet saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 3,010,000 shares, an increase of 26.5% from the January 31st total of 2,380,000 shares. Based on an average daily trading volume, of 1,450,000 shares, the short-interest ratio is currently 2.1 days.
View Zimmer Biomet's Short Interest.
When is Zimmer Biomet's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023.
View our ZBH earnings forecast.
How were Zimmer Biomet's earnings last quarter?: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) announced its quarterly earnings data on Friday, February, 3rd. The medical equipment provider reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.83 by $0.05. The medical equipment provider had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.76 billion. Zimmer Biomet had a net margin of 3.33% and a trailing twelve-month return on equity of 11.97%. Zimmer Biomet's quarterly revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.95 earnings per share.
Read the conference call transcript.
How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?: Zimmer Biomet declared a quarterly dividend on Wednesday, March 8th. Investors of record on Wednesday, March 29th will be given a dividend of $0.24 per share on Friday, April 28th. This represents a $0.96 annualized dividend and a yield of 0.74%. The ex-dividend date of this dividend is Tuesday, March 28th.
Read our dividend analysis for ZBH.
What ETFs hold Zimmer Biomet's stock?: ETFs with the largest weight of Zimmer Biomet (NYSE:ZBH) stock in their portfolio include Leatherback Long/Short Alternative Yield ETF (LBAY), American CenturyFocused Large Cap Value ETF (FLV), iShares U.S. Medical Devices ETF (IHI), VanEck Morningstar Wide Moat ETF (MOAT), Goldman Sachs Future Health Care Equity ETF (GDOC), FIS Biblically Responsible Risk Managed ETF (PRAY), ALPS Hillman Active Value ETF (HVAL) and First Trust Indxx Medical Devices ETF (MDEV).
Is Zimmer Biomet a good dividend stock?: Zimmer Biomet (NYSE:ZBH) pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.76%. The dividend payout ratio is 87.27%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, ZBH will have a dividend payout ratio of 12.72% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ZBH.

What guidance has Zimmer Biomet issued on next quarter's earnings?: Zimmer Biomet updated its FY23 earnings guidance on Friday, February, 3rd. The company provided EPS guidance of $6.95-7.15 for the period, compared to the consensus EPS estimate of $6.99. The company issued revenue guidance of +1.5-3.5% to ~$7.04-7.18 billion, compared to the consensus revenue estimate of $7.00 billion.
What is Bryan Hanson's approval rating as Zimmer Biomet's CEO?: 240 employees have rated Zimmer Biomet Chief Executive Officer Bryan Hanson on Glassdoor.com. Bryan Hanson has an approval rating of 87% among the company's employees. 66.0% of employees surveyed would recommend working at Zimmer Biomet to a friend.
What other stocks do shareholders of Zimmer Biomet own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Cisco Systems (CSCO), Merck & Co., Inc. (MRK), Intel (INTC), AbbVie (ABBV), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).
What is Zimmer Biomet's stock symbol?: Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."
How do I buy shares of Zimmer Biomet?: Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Zimmer Biomet's stock price today?: One share of ZBH stock can currently be purchased for approximately $129.20.
How much money does Zimmer Biomet make?: Zimmer Biomet (NYSE:ZBH) has a market capitalization of $27.00 billion and generates $6.94 billion in revenue each year. The medical equipment provider earns $231.40 million in net income (profit) each year or $1.10 on an earnings per share basis.
How many employees does Zimmer Biomet have?: The company employs 18,000 workers across the globe.
Does Zimmer Biomet have any subsidiaries?: The following companies are subsidiares of Zimmer Biomet: Abbott Spine, Beijing Montagne Medical Device Co. Ltd., Beijing Montagne Medical Device Co. Ltd., BioMet, Biomet 3i Australia Pty. Ltd., Biomet 3i Belgium N.V., Biomet 3i Benelux Holdings N.V., Biomet 3i Dental Iberica SL, Biomet 3i LLC, Biomet 3i Mexico S.A. de C.V., Biomet 3i Netherlands B.V., Biomet 3i Nordic AB, Biomet 3i Portugal Lda, Biomet 3i Switzerland GmbH, Biomet 3i Turkey, Biomet 3i UK Ltd., Biomet 3i do Brasil Comercio de Aparelhos Medicos Ltda., Biomet Acquisitions (Unlimited), Biomet Argentina SA, Biomet Australia Pty. Ltd., Biomet Biologics LLC, Biomet Brazil Medical Device Ltda., Biomet C.V., Biomet CV Holdings LLC, Biomet Cementing Technologies AB, Biomet Chile SA, Biomet China Co. Ltd., Biomet Deutschland GmbH, Biomet Deutschland Holding GmbH, Biomet Fair Lawn LLC, Biomet Finance US LLC, Biomet France Sarl, Biomet Global Supply Chain Center B.V., Biomet Healthcare Management GmbH, Biomet Holdings B.V., Biomet Hong Kong CBT Ltd., Biomet Hong Kong Holding Ltd., Biomet Hong Kong No. 1 Ltd., Biomet Inc., Biomet Insurance Ltd., Biomet International Inc., Biomet International Orthopedics LLC, Biomet Leasing Inc., Biomet Manufacturing LLC, Biomet Mexico S.A. de C.V., Biomet Microfixation B.V., Biomet Orthopedics LLC, Biomet Orthopedics Puerto Rico Inc., Biomet Spain Orthopaedics S.L., Biomet Sports Medicine LLC, Biomet Trauma LLC, Biomet U.S. Reconstruction LLC, Biomet UK Healthcare Ltd., Biomet UK Ltd., CD Diagnostics, CD Diagnostics Inc., CD Laboratories Inc., Cayenne Medical, Cayenne Medical Inc., CelgenTek Innovations Corporation, Centerpulse Ltd, Changzhou Biomet Medical Devices Co. Ltd., Citra Labs LLC, Clinical Graphics, Compression Therapy Concepts Inc., Compression Therapy Products, D.S. Comp Ltd., Dornoch Medical Systems, Dornoch Medical Systems Inc., EBI Holdings LLC, EBI LLC, EBI Medical Systems LLC, EBI Patient Care Inc., ETEX Corporation, ETEX Holdings Inc., Electro-Biology LLC, Endius, Espanormed S.L., Etex, ExtraOrtho, Hakuho Company Ltd., IC Guided Surgery SRL, Implant Concierge LLC, Implant Innovations Holdings LLC, Implex, InnoVision Inc., Interpore Cross International LLC, JERDS Luxembourg Holding Sarl, Kirschner Medical Corporation, Knee Creations, LDR Brasil Comercio Importacao e Exportacao Ltda., LDR Holding, LDR Medical Hong Kong (branch), LDR Médical S.A.S., LVB Acquisition Inc., Lanx Puerto Rico LLC , Lanx Srl, Medical Compression Systems Inc., Medtech SA, Medtech SAS, Medtech Surgical GmbH, Medtech Surgical Inc., NORMED Medizin-Technik GmbH, ORTHOsoft ULC, Ortho Transmission, Orthopaedic Advantage LLC, Ospol Participacoes Ltda., Representaciones Zimmer Inc. S. de R.L. de C.V., Respondwell, SM Re Ltd., Scandimed Holding AB, Shanghai Biomet Business Consulting Co. Ltd., Synvasive Technology, Synvasive Technology Inc., ZB COOP C.V., ZB COOP LLC, ZB Cayman (Asia) Holding Ltd., ZB Cayman Island CBT 2 Ltd., ZB Dental India Private Limited, ZB EMEA 1 LP, ZB EMEA Finance UK 1 Ltd., ZB EMEA Finance UK 2 Ltd., ZB EMEA Finance UK 3 Ltd., ZB EMEA US UK LLC, ZB Hong Kong CBT 2 Ltd., ZB Hong Kong Holding Ltd., ZB Hong Kong Ltd., ZB Manufacturing LLC, ZB UK Group Holdings Limited, ZH2LX Barbados Branch (branch), Zfx, Zfx GmbH, Zfx Innovation GmbH, Zhejiang Biomet Medical Products Co. Ltd., Zimmer (Shanghai) Medical International Trading Co. Ltd., Zimmer Asia (HK) Ltd., Zimmer Australia Holding Pty. Ltd., Zimmer Biomet (Thailand) Co. Ltd., Zimmer Biomet Asel Alarabiya Limited Company, Zimmer Biomet Asia Holding B.V., Zimmer Biomet Asia Holdings Pte. Ltd., Zimmer Biomet Austria GmbH, Zimmer Biomet BVBA, Zimmer Biomet CBT, Zimmer Biomet CBT 2, Zimmer Biomet CMF and Thoracic LLC, Zimmer Biomet Canada Inc., Zimmer Biomet Centroamerica SA, Zimmer Biomet Comp Ltd., Zimmer Biomet Denmark ApS, Zimmer Biomet Dental Canada Inc., Zimmer Biomet Dental K.K., Zimmer Biomet Deutschland GmbH, Zimmer Biomet Distribution LLC, Zimmer Biomet Finance Srl, Zimmer Biomet Finance US Holding Inc., Zimmer Biomet Finland Oy, Zimmer Biomet France Holdings SAS, Zimmer Biomet France SAS, Zimmer Biomet GK, Zimmer Biomet Global Holdings Switzerland GmbH, Zimmer Biomet Hellas SA, Zimmer Biomet Ireland Limited, Zimmer Biomet Italia Srl, Zimmer Biomet Korea Ltd., Zimmer Biomet Nederland B.V., Zimmer Biomet New Zealand Company, Zimmer Biomet Norway AS, Zimmer Biomet OUS Holdings AG, Zimmer Biomet Polska Sp. z.o.o, Zimmer Biomet Portugal Unipessoal Lda, Zimmer Biomet Pty. Ltd., Zimmer Biomet Romania S.R.L., Zimmer Biomet South Africa (Pty) Ltd., Zimmer Biomet Spain S.L., Zimmer Biomet Spine Inc., Zimmer Biomet Sweden AB, Zimmer Biomet Taiwan Co. Ltd., Zimmer Biomet UK Ltd., Zimmer Biomet US 2 Holding Inc., Zimmer CBT I Holding Inc., Zimmer CBT II Holding Inc., Zimmer CEP USA Holding Co., Zimmer CEP USA Inc., Zimmer CIS Ltd., Zimmer CV Inc., Zimmer Caribe LLC, Zimmer Cayman Islands Holding Co. Ltd., Zimmer Co-op Holdings LLC, Zimmer Colombia SAS, Zimmer Czech sro, Zimmer Dental (Shanghai) Medical Device Co. Ltd., Zimmer Dental Chile Spa, Zimmer Dental GmbH, Zimmer Dental Inc., Zimmer Dental Italy Srl, Zimmer Dental Ltd., Zimmer Dental SAS, Zimmer Finance Ireland, Zimmer France Manufacturing Sarl, Zimmer Germany Holdings GmbH, Zimmer GmbH, Zimmer GmbH Euro IP Branch (branch), Zimmer GmbH Winterthur Branch (branch), Zimmer Gulf FZ LLC, Zimmer Inc., Zimmer India Private Ltd., Zimmer International Logistics GmbH, Zimmer Investments LLC, Zimmer Knee Creations Inc., Zimmer Luxembourg II Sarl, Zimmer Luxembourg Sarl, Zimmer Manufacturing B.V., Zimmer Manufacturing B.V. (branch), Zimmer Medical Malaysia SDN BHD, Zimmer Netherlands Cooperatief U.A., Zimmer Orthobiologics Inc., Zimmer Orthopedics Manufacturing Limited, Zimmer Production Inc., Zimmer Pte. Ltd., Zimmer Slovakia sro, Zimmer Southeast Florida LLC, Zimmer Spine Next Inc., Zimmer Spine SAS, Zimmer Surgical, Zimmer Surgical Inc., Zimmer Surgical SA, Zimmer Switzerland Holdings LLC, Zimmer Switzerland Manufacturing GmbH, Zimmer Tibbi Cihazlar Sanayi ve Ticaret AS, Zimmer Trabecular Metal Technology Inc., Zimmer Trustee Ltd., Zimmer UK Limited, Zimmer US Inc., and Zimmer do Brasil Comercio Ltda..
Read More
How can I contact Zimmer Biomet?: Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The official website for the company is www.zimmerbiomet.com. The medical equipment provider can be reached via phone at (574) 267-6131, via email at keri.mattox@zimmerbiomet.com, or via fax at 574-372-4988.

This page (NYSE:ZBH) was last updated on 4/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Zimmer Biomet - ZBH Stock Forecast, Price & News

Zimmer Biomet MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Zimmer Biomet (NYSE:ZBH) Stock

ZBH Stock News Headlines

ZBH Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

ZBH Stock - Frequently Asked Questions

Overall MarketRank^™